• Aucun résultat trouvé

Kala-azar in Nepal: public health evidence to support the elimination initiative

N/A
N/A
Protected

Academic year: 2021

Partager "Kala-azar in Nepal: public health evidence to support the elimination initiative"

Copied!
6
0
0

Texte intégral

(1)

Promoter:

Prof. Dr. Bruno DUJARDIN

Research Center "Policies and Health Systems – International Health"

School of Public Health Université libre de Bruxelles Brussels, Belgium

Kala-azar in Nepal: public health evidence to support the elimination initiative

Surendra Kumar URANW

Co-promoter(s):

Prof. Dr. Marleen BOELAERT Unit of Epidemiology and Control of Tropical Disease

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium

Prof. Dr. Suman RIJAL

Department of Internal Medicine and Tropical & Infectious Disease Centre B.P. Koirala Institute of Health Sciences

Dharan, Nepal

Dépôt Légal : D/2013/Surendra Kumar URANW, Auteur-Éditeur

DoCToRAL THESIS PRESENTED To oBTAIN THE DEgREE of DoCToR IN PUBLIC HEALTH SCIENCES September 2013

É c o l e d e S a n t É P u b l i q u e

(2)
(3)

Doctoral committee

Promoter

Prof. Dr. Bruno Dujardin,

Research Center: "Policies and Health Systems – International Health"

School of Public Health, Université Libre de Bruxelles, Belgium

Co-promoter(s)

Prof. Dr. Marleen Boelaert,

Unit of Epidemiology and Control of Tropical Disease

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium Prof. Dr. Suman Rijal,

Department of Internal Medicine and Tropical & Infectious Disease Center B.P. Koirala Institute of Health Sciences, Dharan, Nepal

Member of the Jury

Prof. Dr. Philippe Donnen (President of the Jury) Policies and Health Systems

School of Public Health, Université Libre de Bruxelles, Belgium Prof. Dr. M. Dramaix

Epidemiology and biostatistics

School of Public Health, Université Libre de Bruxelles, Belgium Prof. Dr. Isabelle Godin (Secretary of the Jury)

Social approaches to health

School of Public Health, Université Libre de Bruxelles, Belgium Prof. Dr. Philippe Goyens

Head of clinic, HUDERF Bruxelles, Belgium Prof. J. Macq

Faculty of Public Health, UCL Bruxelles, Belgium

(4)
(5)

Dedicated to my beloved late mother (the fountain of inspiration)

(6)

Références

Documents relatifs

During 2018, the EMHJ published two special issues – “Scaling up action on the prevention and control of non-communicable diseases in the Eastern Mediterranean Region” (7)

Après le lancement de la politique nationale de santé de 2002, des changements majeurs de paradigme ont été adoptés: toutes les principales interventions de lutte

Final cure rate (%): number of patients with final cure/total number who started treatment. Final cure in PKDL: clinical cure 12 months after end of treatment – defined as

 Contribution to elimination of VL with integrated activities: active VL and PKDL case detection and treatment free of charge, and support to vector control

The global strategy to eliminate cervical cancer as a public health problem will require (a) political support from international and local leaders; (b) coordinated cooperation

This book is designed to provide public health professionals, policy-makers, programme managers and students of public health with an important resource; one that will be

ةروصب متي ملو ؟لعفلاب اهفده ققحت يتلا ةينلاعلإا تاقصلملا فرعن نأ انل فيك باتكلا اذه ضرعي لاو ،ةمخضلا يعامتجلاا قيوستلا تلامح مييقت وأ يصقت ةيجهنم

(1) to note that urgent action is needed to scale up implementation of proven cost-effective measures towards achieving the elimination of cervical cancer as a